Company Name: Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of therapies for orphan and rare diseases with a focus on lysosomal storage disorders. The company’s pipeline includes product candidates designed to treat Fabry disease, Epidermolysis Bullosa and Pompe disease.

Ticker Symbol: FOLD (NASDAQ)

Company Website:

Social Media:

Amicus Therapeutics Facebook

Amicus Therapeutics LinkedIn

Amicus Therapeutics Twitter

Headquarters: Cranbury, NJ